At Novo, I review KYC/AML cases and investigate transaction patterns, alerts, and potential money-laundering red flags. I conduct enhanced due diligence, assess risk, and screen clients for sanctions, PEPs, and adverse media.
I also created productivity and QA trackers, an AML training roadmap, and a KYC training document, and I train new joiners and manage alert queues. Earlier at Panav Biotech, I completed enhanced due diligence on business alliances and assisted the director as a commercial associate.
